Danske Bank’s Novo Nordisk NVO Stock Holding History

Danske Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$320K	Buy	10,000 +6,700	+203%	+$288K	﹤0.01%	640
2026 Q1	$45.4K	Buy	+3,300	New	+$156K	﹤0.01%	703

Other funds holding NVO

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Danske Bank's NVO Position: Q1 2026 in Review

Danske Bank sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 10,000 shares — an estimated $474K sold.

Danske Bank first reported a position in NVO in Q1 2024 and held it in 2 quarters. The position peaked at $8.71M in Q1 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Danske Bank reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Danske Bank sold 10,000 Novo Nordisk shares in Q1 2026, an estimated $474K.
Danske Bank first reported a position in Novo Nordisk in Q1 2024 and held it in 2 quarters.
Danske Bank's Novo Nordisk position peaked at $8.71M in Q1 2024.
1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.